Relationship of cytokines to symptom distress and symptom clusters among non-small-cell lung cancer patients receiving gefitinib treatment: A pilot study

Shu Yi Wang, Chun Ming Tsai, Chia-Chin Lin

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Several cytokines involved in the development of sickness behaviors are considered to be related to the development of cancer symptoms. However, the mechanism of cytokines' involvement in symptom relief with gefitinib treatment remains unknown. This study analyzed the relationships between single symptoms/symptom clusters and cytokines in patients with advanced non-small-cell lung cancer (NSCLC) at pretreatment and at 1 month, 3 months, and 6 months after gefitinib treatment. Methods: Fifty-seven patients with NSCLC were recruited via convenience sampling from a group of thoracic oncology patients in Northern Taiwan. Research measures included the use of the M.D. Anderson Symptom Inventory-Taiwan form and enzyme-linked immunosorbent assays. Statistical analyses included descriptive statistics and generalized estimating equation analysis. Results: Positive relationships were observed between interleukin (IL)-2 and nausea (p

Original languageEnglish
Pages (from-to)50-56
Number of pages7
JournalJournal of Experimental and Clinical Medicine(Taiwan)
Volume6
Issue number2
DOIs
Publication statusPublished - 2014

Fingerprint

Non-Small Cell Lung Carcinoma
Cytokines
Taiwan
Illness Behavior
Nausea
Interleukin-2
Thorax
Therapeutics
Enzyme-Linked Immunosorbent Assay
Equipment and Supplies
Research
gefitinib
Neoplasms

Keywords

  • Cytokines
  • Gefitinib therapy
  • Non-small-cell lung cancer
  • Symptom cluster

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{2f1e45d0f3a547b58132028ce35c59d6,
title = "Relationship of cytokines to symptom distress and symptom clusters among non-small-cell lung cancer patients receiving gefitinib treatment: A pilot study",
abstract = "Purpose: Several cytokines involved in the development of sickness behaviors are considered to be related to the development of cancer symptoms. However, the mechanism of cytokines' involvement in symptom relief with gefitinib treatment remains unknown. This study analyzed the relationships between single symptoms/symptom clusters and cytokines in patients with advanced non-small-cell lung cancer (NSCLC) at pretreatment and at 1 month, 3 months, and 6 months after gefitinib treatment. Methods: Fifty-seven patients with NSCLC were recruited via convenience sampling from a group of thoracic oncology patients in Northern Taiwan. Research measures included the use of the M.D. Anderson Symptom Inventory-Taiwan form and enzyme-linked immunosorbent assays. Statistical analyses included descriptive statistics and generalized estimating equation analysis. Results: Positive relationships were observed between interleukin (IL)-2 and nausea (p",
keywords = "Cytokines, Gefitinib therapy, Non-small-cell lung cancer, Symptom cluster",
author = "Wang, {Shu Yi} and Tsai, {Chun Ming} and Chia-Chin Lin",
year = "2014",
doi = "10.1016/j.jecm.2014.02.009",
language = "English",
volume = "6",
pages = "50--56",
journal = "Journal of Experimental and Clinical Medicine",
issn = "1878-3317",
publisher = "Elsevier Taiwan LLC",
number = "2",

}

TY - JOUR

T1 - Relationship of cytokines to symptom distress and symptom clusters among non-small-cell lung cancer patients receiving gefitinib treatment

T2 - A pilot study

AU - Wang, Shu Yi

AU - Tsai, Chun Ming

AU - Lin, Chia-Chin

PY - 2014

Y1 - 2014

N2 - Purpose: Several cytokines involved in the development of sickness behaviors are considered to be related to the development of cancer symptoms. However, the mechanism of cytokines' involvement in symptom relief with gefitinib treatment remains unknown. This study analyzed the relationships between single symptoms/symptom clusters and cytokines in patients with advanced non-small-cell lung cancer (NSCLC) at pretreatment and at 1 month, 3 months, and 6 months after gefitinib treatment. Methods: Fifty-seven patients with NSCLC were recruited via convenience sampling from a group of thoracic oncology patients in Northern Taiwan. Research measures included the use of the M.D. Anderson Symptom Inventory-Taiwan form and enzyme-linked immunosorbent assays. Statistical analyses included descriptive statistics and generalized estimating equation analysis. Results: Positive relationships were observed between interleukin (IL)-2 and nausea (p

AB - Purpose: Several cytokines involved in the development of sickness behaviors are considered to be related to the development of cancer symptoms. However, the mechanism of cytokines' involvement in symptom relief with gefitinib treatment remains unknown. This study analyzed the relationships between single symptoms/symptom clusters and cytokines in patients with advanced non-small-cell lung cancer (NSCLC) at pretreatment and at 1 month, 3 months, and 6 months after gefitinib treatment. Methods: Fifty-seven patients with NSCLC were recruited via convenience sampling from a group of thoracic oncology patients in Northern Taiwan. Research measures included the use of the M.D. Anderson Symptom Inventory-Taiwan form and enzyme-linked immunosorbent assays. Statistical analyses included descriptive statistics and generalized estimating equation analysis. Results: Positive relationships were observed between interleukin (IL)-2 and nausea (p

KW - Cytokines

KW - Gefitinib therapy

KW - Non-small-cell lung cancer

KW - Symptom cluster

UR - http://www.scopus.com/inward/record.url?scp=84897979138&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897979138&partnerID=8YFLogxK

U2 - 10.1016/j.jecm.2014.02.009

DO - 10.1016/j.jecm.2014.02.009

M3 - Article

AN - SCOPUS:84897979138

VL - 6

SP - 50

EP - 56

JO - Journal of Experimental and Clinical Medicine

JF - Journal of Experimental and Clinical Medicine

SN - 1878-3317

IS - 2

ER -